UniProt ID | PTK6_HUMAN | |
---|---|---|
UniProt AC | Q13882 | |
Protein Name | Protein-tyrosine kinase 6 | |
Gene Name | PTK6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 451 | |
Subcellular Localization | Cytoplasm. Nucleus. Cell projection, ruffle. Membrane. Colocalizes with KHDRBS1, KHDRBS2 or KHDRBS3, within the nucleus. Nuclear localization in epithelial cells of normal prostate but cytoplasmic localization in cancer prostate. | |
Protein Description | Non-receptor tyrosine-protein kinase implicated in the regulation of a variety of signaling pathways that control the differentiation and maintenance of normal epithelia, as well as tumor growth. Function seems to be context dependent and differ depending on cell type, as well as its intracellular localization. A number of potential nuclear and cytoplasmic substrates have been identified. These include the RNA-binding proteins: KHDRBS1/SAM68, KHDRBS2/SLM1, KHDRBS3/SLM2 and SFPQ/PSF; transcription factors: STAT3 and STAT5A/B and a variety of signaling molecules: ARHGAP35/p190RhoGAP, PXN/paxillin, BTK/ATK, STAP2/BKS. Associates also with a variety of proteins that are likely upstream of PTK6 in various signaling pathways, or for which PTK6 may play an adapter-like role. These proteins include ADAM15, EGFR, ERBB2, ERBB3 and IRS4. In normal or non-tumorigenic tissues, PTK6 promotes cellular differentiation and apoptosis. In tumors PTK6 contributes to cancer progression by sensitizing cells to mitogenic signals and enhancing proliferation, anchorage-independent survival and migration/invasion. Association with EGFR, ERBB2, ERBB3 may contribute to mammary tumor development and growth through enhancement of EGF-induced signaling via BTK/AKT and PI3 kinase. Contributes to migration and proliferation by contributing to EGF-mediated phosphorylation of ARHGAP35/p190RhoGAP, which promotes association with RASA1/p120RasGAP, inactivating RhoA while activating RAS. EGF stimulation resulted in phosphorylation of PNX/Paxillin by PTK6 and activation of RAC1 via CRK/CrKII, thereby promoting migration and invasion. PTK6 activates STAT3 and STAT5B to promote proliferation. Nuclear PTK6 may be important for regulating growth in normal epithelia, while cytoplasmic PTK6 might activate oncogenic signaling pathways.; Isoform 2 inhibits PTK6 phosphorylation and PTK6 association with other tyrosine-phosphorylated proteins.. | |
Protein Sequence | MVSRDQAHLGPKYVGLWDFKSRTDEELSFRAGDVFHVARKEEQWWWATLLDEAGGAVAQGYVPHNYLAERETVESEPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRRAGGRLHLNEAVSFLSLPELVNYHRAQSLSHGLRLAAPCRKHEPEPLPHWDDWERPREEFTLCRKLGSGYFGEVFEGLWKDRVQVAIKVISRDNLLHQQMLQSEIQAMKKLRHKHILALYAVVSVGDPVYIITELMAKGSLLELLRDSDEKVLPVSELLDIAWQVAEGMCYLESQNYIHRDLAARNILVGENTLCKVGDFGLARLIKEDVYLSHDHNIPYKWTAPEALSRGHYSTKSDVWSFGILLHEMFSRGQVPYPGMSNHEAFLRVDAGYRMPCPLECPPSVHKLMLTCWCRDPEQRPCFKALRERLSSFTSYENPT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | QAHLGPKYVGLWDFK HCCCCCCCEEEEECC | 11.68 | 19060867 | |
61 | Phosphorylation | GGAVAQGYVPHNYLA CCCCCCCCCCHHHEE | 9.95 | 12121988 | |
66 | Phosphorylation | QGYVPHNYLAERETV CCCCCHHHEEECEEC | 12.31 | 12121988 | |
111 | Phosphorylation | IRVSEKPSADYVLSV EEECCCCCCCEEEEE | 44.85 | 28152594 | |
114 | Phosphorylation | SEKPSADYVLSVRDT CCCCCCCEEEEECCC | 11.73 | 21082442 | |
117 | Phosphorylation | PSADYVLSVRDTQAV CCCCEEEEECCCHHH | 12.69 | 28152594 | |
127 | Phosphorylation | DTQAVRHYKIWRRAG CCHHHHHHHHHHHCC | 8.13 | - | |
159 | Phosphorylation | VNYHRAQSLSHGLRL HCHHHHHHHHHHHHH | 30.75 | 17192257 | |
161 | Phosphorylation | YHRAQSLSHGLRLAA HHHHHHHHHHHHHCC | 22.28 | 23312004 | |
222 | Phosphorylation | QVAIKVISRDNLLHQ HHHHHHHCCCCHHHH | 36.25 | 30206219 | |
271 | Phosphorylation | TELMAKGSLLELLRD HHHHHCCCHHHHHCC | 29.13 | 29457462 | |
279 | Phosphorylation | LLELLRDSDEKVLPV HHHHHCCCCCCEECH | 41.03 | - | |
342 | Phosphorylation | RLIKEDVYLSHDHNI HHHHCCEECCCCCCC | 18.14 | 25159151 | |
344 | Phosphorylation | IKEDVYLSHDHNIPY HHCCEECCCCCCCCC | 14.80 | 26356563 | |
351 | Phosphorylation | SHDHNIPYKWTAPEA CCCCCCCCEECCCHH | 18.50 | 27259358 | |
352 | Ubiquitination | HDHNIPYKWTAPEAL CCCCCCCEECCCHHH | 32.49 | 29967540 | |
442 | Phosphorylation | KALRERLSSFTSYEN HHHHHHHHHCCCCCC | 29.62 | 28152594 | |
443 | Phosphorylation | ALRERLSSFTSYENP HHHHHHHHCCCCCCC | 36.82 | 28152594 | |
445 | Phosphorylation | RERLSSFTSYENPT- HHHHHHCCCCCCCC- | 32.14 | 28152594 | |
446 | Phosphorylation | ERLSSFTSYENPT-- HHHHHCCCCCCCC-- | 28.56 | 22617229 | |
447 | Phosphorylation | RLSSFTSYENPT--- HHHHCCCCCCCC--- | 19.37 | 17822667 | |
451 | Phosphorylation | FTSYENPT------- CCCCCCCC------- | 63.93 | 26356563 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
13 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
61 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
66 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
114 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
342 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | PhosphoELM |
351 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
447 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | PhosphoELM |
447 | Y | Phosphorylation | Kinase | SRMS | Q9H3Y6 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTK6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTK6_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KHDR1_HUMAN | KHDRBS1 | physical | 10913193 | |
A4_HUMAN | APP | physical | 21832049 | |
ERBB2_HUMAN | ERBB2 | physical | 18719096 | |
PTK6_HUMAN | PTK6 | physical | 18719096 | |
REL_HUMAN | REL | physical | 25416956 | |
WASL_HUMAN | WASL | physical | 25416956 | |
EXOC5_HUMAN | EXOC5 | physical | 25416956 | |
FCHO1_HUMAN | FCHO1 | physical | 25416956 | |
CCD33_HUMAN | CCDC33 | physical | 25416956 | |
EFHC2_HUMAN | EFHC2 | physical | 25416956 | |
KHDR2_HUMAN | KHDRBS2 | physical | 25416956 | |
SOCS3_HUMAN | SOCS3 | physical | 22547065 | |
TCPG_HUMAN | CCT3 | physical | 25852190 | |
TCPD_HUMAN | CCT4 | physical | 25852190 | |
TCPQ_HUMAN | CCT8 | physical | 25852190 | |
TCPA_HUMAN | TCP1 | physical | 25852190 | |
PTK6_HUMAN | PTK6 | physical | 26751287 | |
HIF1A_HUMAN | HIF1A | physical | 26751287 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB05294 | Vandetanib |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-114 AND SER-159, ANDMASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASSSPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASSSPECTROMETRY. |